Whether the response of rectal cancer to nCRT is associated with the somatic mutations of KRAS or APC and infiltration of activated CD4+ T cells, NK cells, dendritic cells, or M2 macrophages should be verified in future investigations. The gene discussed is KRAS; the disease is rectal cancer.